/Investor DB

Bullpen Capital — 2022 Investments

5 investments dated 2022 · listed companies and verified rows first · show all

Drafteadraftea.mx𝕏Sep 2022

Draftea operates a mobile sports betting app offering live in-play betting with real-time odds across sports including soccer, American football, basketball, baseball, and F1.

ConsumerGamingSports Tech

Alán Jaime Misrahi(Founder)inJoe Cohen(Founder)inAlan Jaime(Founder)Andreas Assad(Founder)

Co-investorsAbstract VenturesCourtside VenturesFJ LabsKaszek VenturesMantis CapitalQP Ventures+5 more

Fanimalfanimal.com𝕏Seed · May 2022 · $4MDefunct

Fanimal is an online ticket marketplace where users can buy and sell tickets to sports events, concerts, and music festivals across leagues including the NFL, NBA, MLB, NHL, MLS, and NCAA.

E-commerceMarketplacesMedia & Entertainment

Jonny Halprin(Founder)in

Co-investorsWestern Technology InvestmentBurst CapitalPear VC

Predictionstrikepredictionstrike.cominSeries A · Aug 2022 · $10M

PredictionStrike operates an online marketplace where sports fans buy and trade virtual shares of professional athletes.

Bay Shore, US

Deven Hurt(Executive Officer, Director)inBrad Chabra(Executive Officer, Director)in

BoardMarlon Nichols(Director)in

Co-investorsElevate CapitalGaingelsSixty8 CapitalCorrelation VenturesHighsage VenturesMaC Venture Capital+1 more

Prevetapreveta.comin𝕏Seed · Dec 2022 · $6M

Preveta provides care navigation technology to healthcare providers, designed to improve care coordination and help patients access support within the healthcare system.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSRedondo Beach, US

Victor Lee(CEO)inShirley Lee(Director)in

BoardAdrian Fenty(Director)in

Co-investorsMaC Venture CapitalNavigate VenturesTechstarsTMVTSVC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Flip CX

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.